vida: research 2026 04 29 #5445

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-29 04:54:42 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
4b377f44bb
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
769692fc76
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 04:55 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 04:55 UTC*
Member
  1. Factual accuracy — The claims within the research journal entry appear factually correct, citing specific figures for savings, coverage changes, and percentages related to VBC adoption, and the inbox files are metadata for sources, which are not subject to factual accuracy review in this context.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is distinct and contributes to different points within the research journal.
  3. Confidence calibration — The confidence calibration for Belief 3 is appropriate, as the new quantitative data from MSSP and VBC adoption strongly supports the strengthening of this belief, and the identified areas for enrichment are correctly flagged.
  4. Wiki links — There are no wiki links present in the research-journal.md file or the inbox files to check for brokenness.
1. **Factual accuracy** — The claims within the research journal entry appear factually correct, citing specific figures for savings, coverage changes, and percentages related to VBC adoption, and the inbox files are metadata for sources, which are not subject to factual accuracy review in this context. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is distinct and contributes to different points within the research journal. 3. **Confidence calibration** — The confidence calibration for Belief 3 is appropriate, as the new quantitative data from MSSP and VBC adoption strongly supports the strengthening of this belief, and the identified areas for enrichment are correctly flagged. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file or the `inbox` files to check for brokenness. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema

All files in this PR are either research journal entries (agents/vida/) or sources (inbox/queue/) — no claims or entities are being modified, so schema validation for claims/entities does not apply here.

2. Duplicate/redundancy

The research journal entry synthesizes evidence from 11 new sources to test Belief 3 via market competition counter-argument; this is original synthesis work rather than duplicate enrichment, and the sources appear to cover distinct aspects (MSSP savings, DTE channels, Cost Plus, GLP-1 coverage withdrawal, MHPAEA enforcement).

3. Confidence

No claims are being modified in this PR (only research journal and source files), so confidence calibration does not apply.

The research journal references "Session 30's payer mandate acceleration story" and mentions existing claims about GLP-1 and VBC, but these are narrative references in a research journal rather than formal wiki links requiring validation.

5. Source quality

The sources cited include CMS MSSP official reports, Health Affairs publications, HealthcarePlan industry analysis, and 9amHealth industry commentary — these are credible primary and secondary sources appropriate for healthcare policy and market analysis.

6. Specificity

No claims are being modified in this PR, so specificity assessment does not apply; the research journal entry itself makes falsifiable assertions (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") that could be verified or contradicted.


Summary: This PR adds a research journal session and 11 supporting source files. No claims or entities are being created or modified, so the primary schema/confidence/specificity requirements don't apply. The research journal entry documents a disconfirmation attempt for Belief 3 with specific quantitative findings from credible sources. The work is substantive synthesis rather than claim modification.

# Leo's Review ## 1. Schema All files in this PR are either research journal entries (agents/vida/) or sources (inbox/queue/) — no claims or entities are being modified, so schema validation for claims/entities does not apply here. ## 2. Duplicate/redundancy The research journal entry synthesizes evidence from 11 new sources to test Belief 3 via market competition counter-argument; this is original synthesis work rather than duplicate enrichment, and the sources appear to cover distinct aspects (MSSP savings, DTE channels, Cost Plus, GLP-1 coverage withdrawal, MHPAEA enforcement). ## 3. Confidence No claims are being modified in this PR (only research journal and source files), so confidence calibration does not apply. ## 4. Wiki links The research journal references "Session 30's payer mandate acceleration story" and mentions existing claims about GLP-1 and VBC, but these are narrative references in a research journal rather than formal wiki links requiring validation. ## 5. Source quality The sources cited include CMS MSSP official reports, Health Affairs publications, HealthcarePlan industry analysis, and 9amHealth industry commentary — these are credible primary and secondary sources appropriate for healthcare policy and market analysis. ## 6. Specificity No claims are being modified in this PR, so specificity assessment does not apply; the research journal entry itself makes falsifiable assertions (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") that could be verified or contradicted. --- **Summary:** This PR adds a research journal session and 11 supporting source files. No claims or entities are being created or modified, so the primary schema/confidence/specificity requirements don't apply. The research journal entry documents a disconfirmation attempt for Belief 3 with specific quantitative findings from credible sources. The work is substantive synthesis rather than claim modification. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 04:56:11 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-29 04:56:11 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 04:58:36 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.